Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles

Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles

Antibody drug conjugates (ADCs) have emerged as a highly effective treatment strategy across breast cancer (BC) subtypes, including human epidermal growth factor receptor 2-positive (HER2+), hormone-receptor positive (ER/PR+), and triple-negative breast cancer (TNBC). Over the past twenty years, ADC...

Full description

Bibliographic Details
Main Authors: Mary Anne Fenton, Paolo Tarantino, Stephanie L. Graff
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Current Oncology
Subjects:
breast cancer
antibody drug conjugates
trastuzumab deruxtecan
sacituzumab govitecan
HER2-low
HER2+
Online Access:https://www.mdpi.com/1718-7729/30/12/743

Internet

https://www.mdpi.com/1718-7729/30/12/743

Similar Items